From: Low flow extracorporeal CO2 removal in ARDS patients: a prospective short-term crossover pilot study
Baseline characteristics | N (%) or median [IQR] |
---|---|
Number of patients included | 10 (100%) |
Age (y) | 50.5 [34.8; 63.3] |
Gender | Male 6 (60%)/female 4 (40%) |
SAPS 3 score | 72.5 [61.0; 79.3] |
Characteristics at inclusion | |
 Length of ICU stay before inclusion (h) | 26 [20.5; 67.5] |
 Days with ARDS criteria on CT scan or chest radiography on the day of inclusion | 2 [1; 3.25] |
 SAPS 3 score | 69.5 [57.75; 79.25] |
 Vasopressor use | 10 (100%) |
 RRT use | 0 |
 PaCO2 (mmHg) | 68.3 [57.7; 86.2] |
 pH | 7.21 [7.11; 7.23] |
 PaO2/FiO2 (mmHg) | 83 [67.6; 121.1] |
 Murray score | 3.5 [3.2; 3.5] |
 Moderate ARDS (PaO2/FiO2: 100–200 mmHg) | 4 (40%) |
 Severe ARDS (PaO2/FiO2 < 100 mmHg) | 6 (60%) |
 Nitric Oxide inhalation | 6 (60%) |
 Neuromuscular blockers | 10 (100%) |
 Prone ventilation | 2 (20%) |
 PPLAT (cmH2O) | 31.5 [28.8; 35.5] |
 Driving pressure (PPLAT –PEEP) (cmH2O) | 19.0 [17.5; 24.0] |
 VT/PBW (mL/kg) | 6.9 [6.31; 7.48] |